ZYVERSA THERAPEUTICS INC (ZVSA) Forecast, Price Target & Analyst Ratings
NASDAQ:ZVSA • US98987D3008
0.3113 USD
-0.24 (-43.3%)
At close: Jul 16, 2025
0.289 USD
-0.02 (-7.16%)
After Hours: 7/16/2025, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZYVERSA THERAPEUTICS INC (ZVSA).
Forecast Snapshot
Consensus Price Target
$122.40
+ 39,218.98% Upside
Next Earnings Forecast
Release DateAug 7, 2025
PeriodQ2 / 2025
EPS Estimate-$0.41
Revenue Estimate
ChartMill Buy Consensus
82.50%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$122.40
Upside
+ 39,218.98%
From current price of $0.31 to mean target of $122.40, Based on 8 analyst forecasts
Low
$121.20
Median
$122.40
High
$126.00
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for ZVSA. The average price target is 122.4 USD. This implies a price increase of 39218.98% is expected in the next year compared to the current price of 0.3113.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
ZVSA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ZVSA.
In the previous month the buy percentage consensus was at a similar level.
ZVSA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 7, 2025
PeriodQ2 / 2025
EPS Estimate-$0.41
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q87.67%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
ZVSA is expected to report earnings on 8/7/2025. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 423.40% | ||||||
| EBITDA YoY % growth | -11.823M | -7.694M 34.92% | -13.823M -79.66% | -14.41M -4.25% | -9.13M 36.64% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.833M | -7.704M 34.89% | -13.833M -79.55% | -14.421M -4.25% | -9.137M 36.64% | N/A -214.26% | N/A -40.67% | N/A -36.24% | N/A -14.07% | N/A 84.51% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 97.53% | N/A 93.00% | N/A -217.07% | N/A -1,091.03% | N/A -22.39% | N/A 17.15% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.41 87.67% | -0.26 89.51% | -0.31 93.36% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-38.29%
EPS Next 5 Year
-21.81%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ZYVERSA THERAPEUTICS INC / ZVSA Forecast FAQ
Can you provide the average price target for ZYVERSA THERAPEUTICS INC stock?
8 analysts have analysed ZVSA and the average price target is 122.4 USD. This implies a price increase of 39218.98% is expected in the next year compared to the current price of 0.3113.
Can you provide the upcoming earnings date for ZYVERSA THERAPEUTICS INC?
ZYVERSA THERAPEUTICS INC (ZVSA) will report earnings on 2025-08-07.
Can you provide the consensus estimates for ZYVERSA THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of ZYVERSA THERAPEUTICS INC (ZVSA) is -0.41 USD and the consensus revenue estimate is 0 USD.
What is the number of analysts for ZVSA stock?
The number of analysts covering ZYVERSA THERAPEUTICS INC (ZVSA) is 8.